2m 2m 2m 2m 2m 2m 2m
AARDVARK THERA (AARD)
NASDAQ
$3.76-$0.21 (-5.26%)
Price as of Jun 03, 2026 7:58 PM EDT- $89.7MMarket Cap
- -65.95%1-Year Change
- BiotechnologyIndustry
AARDVARK THERA (AARD)
$3.76-$0.21 (-5.26%)
Annual
Quarterly
12/31/2025 | ||
|---|---|---|
Income Statement | ||
Total Operating Revenue | -5,000 N/A | |
Cost of Revenue | N/A N/A | |
Gross Profit | -5,000 N/A | |
Sales and Marketing Expense | N/A N/A | |
Research and Development Expense | -48.9M N/A | |
Depreciation and Amortization Expense | 36,000 N/A | |
Total Operating Expenses | 62.7M N/A | |
Operating Profit | -62.7M N/A | |
Interest Income | 5.1M N/A | |
Interest Expense | N/A N/A | |
Interest Income and Expense and Net | 5.1M N/A | |
Total Nonoperating Income and Expense | 5.1M N/A | |
Income before Taxes | -62.7M N/A | |
Income Taxes | 0 N/A | |
Extraordinary Items | N/A N/A | |
Net Income | -57.6M N/A | |
Net Income from Continuing Operations Applicable to Common | -57.6M N/A | |
Basic EPS and Net Income | -2.93 N/A | |
Diluted EPS and Net Income | -2.93 N/A | |
Basic Weighted Average Shares | 19.6M N/A | |
Diluted Weighted Average Shares | 19.6M N/A | |
Balance Sheet | ||
Cash and Cash Equivalents | 47.1M N/A | |
Short-Term Investments | 63.0M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 110.0M N/A | |
Total Current Assets | 111.9M N/A | |
Accumulated Depreciation | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | |
Total Long-Term Assets | 4.9M N/A | |
Total Assets | 117.2M N/A | |
Income Taxes Payable | N/A N/A | |
Total Short-Term Debt | N/A N/A | |
Total Current Liabilities | 10.5M N/A | |
Total Long-Term Debt | N/A N/A | |
Total Long-Term Liabilities | 0 N/A | |
Total Liabilities | 10.5M N/A | |
Retained Earnings | -115.9M N/A | |
Total Stockholders Equity | 106.6M N/A | |
Total Shares Outstanding | 21.8M N/A | |
Cash Flow | ||
Cash from Operating Activities | -54.2M N/A | |
Capital Expenditures | 95,000 N/A | |
Cash from Investing Activities | -49.7M N/A | |
Dividends Paid | N/A N/A | |
Cash from Financing Activities | 89.2M N/A | |
Financials Ratio | ||
Gross Margin | N/A N/A | |
Operating Margin | N/A N/A | |
Return on Assets | N/A N/A | |
Return on Equity | N/A N/A | |
Revenue Growth | N/A N/A | |
Current Ratio | N/A N/A | |
Cash Ratio | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow